| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/22/2008 | US20080118442 Aerosol Formulations for Delivery of Dihydroergotamine to the Systemic Circulations Via Pulmonary Inhalation |
| 05/22/2008 | US20080118441 Nutraceutical; omega fatty acids; mucilaginous fiber; no glutamine; gastroesophageal reflux disease, heartburn, acid indigestion, constipation, irritable bowel syndrome |
| 05/22/2008 | US20080118435 Composition comprising low density microspheres |
| 05/22/2008 | US20080116608 Molded waveguides |
| 05/22/2008 | US20080115846 Aqueous fluid photoprotective compositions comprising ester-terminated poly(ester amide) polymers |
| 05/22/2008 | US20080115782 Pressurised metered dose inhalers (mdi) |
| 05/22/2008 | US20080115559 Method for Operating a Reservoir-Based Sensor Device |
| 05/22/2008 | US20080115361 Protecting chemicals and devices from exposure to environment until usage; covering each individual opening with removable barrier layer; eliminates microvalves; controlled in vivo drug release |
| 05/22/2008 | CA2678225A1 Transnasal anticonvulsive pharmaceutical composition |
| 05/22/2008 | CA2678131A1 Colonic delivery using zn/pectin beads with a eudragit coating. |
| 05/22/2008 | CA2669756A1 Improvements in or relating to organic compounds |
| 05/22/2008 | CA2669642A1 Punctal plug comprising a water-insoluble polymeric matrix |
| 05/22/2008 | CA2669539A1 Topical compositions comprising polyhydroxy acids and/or lactones for improved cutaneous effects of oxidative therapeutic drugs |
| 05/22/2008 | CA2669489A1 Liquid pharmaceutical compositions comprising a bisphosphonate compound |
| 05/22/2008 | CA2669488A1 Pharmaceutical compositions comprising a bisphosphonate compound |
| 05/22/2008 | CA2669415A1 Solid dosage form comprising ap23573 |
| 05/22/2008 | CA2669345A1 Immunogenic affinity-conjugated antigen systems based on papaya mosaic virus and uses thereof |
| 05/22/2008 | CA2669233A1 Absorbent composition for surface treatment |
| 05/22/2008 | CA2668885A1 Method for administering weight loss medications |
| 05/22/2008 | CA2668884A1 Layered pharmaceutical formulations |
| 05/22/2008 | CA2668724A1 Darusentan oral dosage form |
| 05/22/2008 | CA2668628A1 Edible emulsions with pgpr |
| 05/22/2008 | CA2664879A1 Biodegradable ocular implants and methods for treating ocular conditions |
| 05/22/2008 | CA2663589A1 Microencapsules containing surface-modified microparticles and methods of forming and using the same |
| 05/22/2008 | CA2659407A1 Nanoparticle compositions |
| 05/22/2008 | CA2611727A1 Adhesive preparation |
| 05/21/2008 | EP1923074A1 Orally disintegratable tablet |
| 05/21/2008 | EP1923059A1 Patch containing a substance selected from tars having reducing characteristics in dermatology |
| 05/21/2008 | EP1923058A1 Coated pharmaceutical composition comprising an S1P agonist or modulator |
| 05/21/2008 | EP1923057A1 Atorvastatin pharmaceutical formulation |
| 05/21/2008 | EP1923056A1 Pharmaceutical single dosage form |
| 05/21/2008 | EP1923055A1 Freeze-dried pharmaceutical composition comprising an S1P agonist or modulator |
| 05/21/2008 | EP1923054A1 Fast disintegrating pharmaceutical composition comprising an S1P agonist or modulator |
| 05/21/2008 | EP1923053A1 Pharmaceutical compositions comprising nilotinib or its salt |
| 05/21/2008 | EP1923052A1 Novel polymorphs and pseudopolymorphs of risedronate sodium |
| 05/21/2008 | EP1923051A1 Microparticle of hardly-soluble substance having enteric base material adsorbed on the surface of the substance |
| 05/21/2008 | EP1923050A1 Liquid pharmaceutical compositions comprising a bisphosphonate compound |
| 05/21/2008 | EP1923049A1 Pharmaceutical compositions comprising a bisphosphonate compound |
| 05/21/2008 | EP1922305A1 New salt ii |
| 05/21/2008 | EP1922090A2 Sanitary napkins with hydrophobic lotions |
| 05/21/2008 | EP1922061A2 Oral solid pharmaceutical formulation of the tribulin inhibitor indibulin |
| 05/21/2008 | EP1922060A2 Intravenous propofol emulsion compositions having preservative efficacy |
| 05/21/2008 | EP1922059A2 Stabilized and preserved ketotifen ophthalmic compositions |
| 05/21/2008 | EP1922058A1 Mouth-moistening compositions, delivery systems containing same and methods of making same |
| 05/21/2008 | EP1921926A2 Food formulation for aquatic animals with integrated targeted delivery of bioactive agents |
| 05/21/2008 | EP1921919A2 Sustained release enhanced lipolytic formulation for regional adipose tissue treatment |
| 05/21/2008 | EP1845949B1 Melt granulation of a composition containing a calcium-containing compound |
| 05/21/2008 | EP1796642B1 Pharmaceutical compositions in the form of solid dispersions for the treatment of cancer |
| 05/21/2008 | EP1742979A4 Method of producing polymeric particles with selected size, shape, morphology and composition |
| 05/21/2008 | EP1730199A4 Native plant cell wall compositions and methods of use |
| 05/21/2008 | EP1713448B1 Stable beadlets of lipophilic nutrients |
| 05/21/2008 | EP1670412B1 Improvements in powder compaction and enrobing |
| 05/21/2008 | EP1663172B1 Polysaccharide double-layer microcapsules as carriers for biologically active substance oral administration |
| 05/21/2008 | EP1569595B1 A method for preparing a medical solution for the manufacture of a medicament for peritoneal dialysis |
| 05/21/2008 | EP1531791A4 Prevention and reduction of blood loss |
| 05/21/2008 | EP1326838B1 Novel crystalline forms of a factor xa inhibitor |
| 05/21/2008 | EP1313453B1 Particulate vectors for improving oral absorption of active principles |
| 05/21/2008 | EP1287130B1 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 05/21/2008 | EP1249239B1 Antipruritic agents for external use |
| 05/21/2008 | EP1140088B1 Controlled/modified release oral methylphenidate formulations |
| 05/21/2008 | DE20221841U1 Transdermal-Pflaster zum Verabreichen von Fentanyl Transdermal patch for administering fentanyl |
| 05/21/2008 | DE102006054679A1 Anti-parasite material for treatment of rooms and objects used for keeping domestic animals or farm animals, contains an enzyme or steroid as lysing agent and at least one active pharmaceutical agent |
| 05/21/2008 | DE102006054638A1 Pharmazeutische Einzeldosisform The pharmaceutical unit dosage form |
| 05/21/2008 | CN101184511A Preparation comprising microparticles of complex composed of nucleic acid molecule and collagen |
| 05/21/2008 | CN101184510A Methods of treating various conditions by administration of sustained release l-arginine |
| 05/21/2008 | CN101184489A Pharmaceutical composition |
| 05/21/2008 | CN101184483A An entacapone-containging oral dosage form |
| 05/21/2008 | CN101184479A Skin patch |
| 05/21/2008 | CN101184478A Method of marking composition for oral administration |
| 05/21/2008 | CN101184477A Controlled release compositions comprising a cephalosporin for the treatment of a bacterial infection |
| 05/21/2008 | CN101184476A Particle size, percent drag effeciency and molecular weight control of bulk polymer polymerized polyalpha-olefins using high shear material processors |
| 05/21/2008 | CN101184475A Transdermal absorption accelerator |
| 05/21/2008 | CN101184474A A closed container comprising an activated factor vii polypeptide, processes for the preparation of the same, and a kit and a method for use of the kit |
| 05/21/2008 | CN101184473A Composition for use in the solubilisation of hydrophobic active agents |
| 05/21/2008 | CN101184470A Cooling compounds |
| 05/21/2008 | CN101182379A Highly inhibited starch fillers for films and capsules |
| 05/21/2008 | CN101181640A Hydrophilicity high elasticity gel rubber stroma of treating medical ointment and preparation method thereof |
| 05/21/2008 | CN101181636A Compound vaccine composition for preventing and controlling human viral infection, compound vaccine vaginal mist and uses thereof |
| 05/21/2008 | CN101181633A Chinese medicine paste for curing oral cavity disease and preparation method thereof |
| 05/21/2008 | CN101181632A Method for preparing superoxide dismutase microcapsule |
| 05/21/2008 | CN101181629A Medicament abundantly containing FN for curing cervical erosion gynecopathy |
| 05/21/2008 | CN101181628A Application of human affinity prime in the preparation of anti-cancer medicament |
| 05/21/2008 | CN101181627A Application of human affinity prime in the preparation of resistance liver cancer medicament |
| 05/21/2008 | CN101181626A Transfer factor capsule and preparation method thereof |
| 05/21/2008 | CN101181625A Chinese medicine prescription for rhinitis as well as preparation method thereof |
| 05/21/2008 | CN101181623A Method for preparing alcohol extraction of white vein ointment |
| 05/21/2008 | CN101181622A Method for preparing water extraction of white vein ointment |
| 05/21/2008 | CN101181621A Chinese medicine paste for preventing and controlling carsickness |
| 05/21/2008 | CN101181620A Pharmaceutical combination for curing chronic bronchitis and bronchial asthma as well as preparation method |
| 05/21/2008 | CN101181619A Method for preparing bolus for reinforcing middle-jiao and replenishing qi |
| 05/21/2008 | CN101181617A Chinese medicine preparation for curing gastrointestinal disease |
| 05/21/2008 | CN101181615A Plaster for curing neck shoulder waist leg pain affection as well as preparation method |
| 05/21/2008 | CN101181608A Medicine for giving up drug |
| 05/21/2008 | CN101181607A Fragrant cream for giving up smoke |
| 05/21/2008 | CN101181605A Capsule for curing medical postoperative colporrhagia as well as preparation method and mass control method |
| 05/21/2008 | CN101181603A Facial palsy correcting paste and preparation method thereof |
| 05/21/2008 | CN101181600A Traditional chinese medicine composition for curing cardiovascular and cerebrovascular diseases |
| 05/21/2008 | CN101181599A Chinese medicine composition for curing chronic pelvic inflammatory disease as well as application thereof |
| 05/21/2008 | CN101181598A Chinese medicine for curingand preparation method thereof hepatism |
| 05/21/2008 | CN101181592A Chinese medicine for curing intractable headache and sick headache |